Occurrence and genetic association of selected virulence factors in clinical Escherichia coli isolates
Language English Country United States Media print
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
11980274
DOI
10.1007/bf02818569
Knihovny.cz E-resources
- MeSH
- Fimbriae, Bacterial genetics MeSH
- Bacterial Toxins genetics metabolism MeSH
- Cytotoxins genetics metabolism MeSH
- Child MeSH
- Adult MeSH
- Escherichia coli genetics pathogenicity MeSH
- Hemolysin Proteins genetics metabolism MeSH
- Escherichia coli Infections microbiology MeSH
- Infant MeSH
- Middle Aged MeSH
- Humans MeSH
- Polymerase Chain Reaction MeSH
- Child, Preschool MeSH
- Escherichia coli Proteins genetics metabolism MeSH
- Sequence Analysis, DNA MeSH
- Virulence genetics MeSH
- Check Tag
- Child MeSH
- Adult MeSH
- Infant MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Child, Preschool MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Bacterial Toxins MeSH
- cytotoxic necrotizing factor type 1 MeSH Browser
- Cytotoxins MeSH
- Hemolysin Proteins MeSH
- Hlya protein, E coli MeSH Browser
- Escherichia coli Proteins MeSH
Occurrence of cnf1+ E. coli pathogenic strains among extraintestinal E. coli isolates was evaluated to explain an impact of cytotoxic necrotizing factor type 1 (CNF1) in human infections. A total of 120 E. coli isolates were characterized for presence of virulence factors cnf1- and pap--specific sequences by PCR, and the production of alpha-hemolysin using blood agar-plate test. Different association patterns among the detected virulence factors were obtained by comparison of various groups of clinical E. coli isolates. These differences probably reflect a potential impact of CNF1 in the colonization of vaginal environment.
See more in PubMed
Lett Appl Microbiol. 2000 Mar;30(3):213-6 PubMed
Clin Microbiol Rev. 1991 Jan;4(1):80-128 PubMed
Infect Immun. 1995 Oct;63(10):3936-44 PubMed
J Clin Microbiol. 1990 Apr;28(4):694-9 PubMed
J Infect Dis. 1997 Aug;176(2):464-9 PubMed
J Infect Dis. 1995 Jun;171(6):1514-21 PubMed
Infect Immun. 1998 Jul;66(7):3384-9 PubMed
Folia Microbiol (Praha). 1998;43(3):285-9 PubMed
J Infect Dis. 2000 Jan;181(1):261-72 PubMed
FEMS Microbiol Lett. 1998 Jul 15;164(2):243-8 PubMed
J Med Microbiol. 1975 Feb;8(1):107-11 PubMed
J Clin Microbiol. 1992 May;30(5):1189-93 PubMed
Folia Microbiol (Praha). 1994;39(2):159-61 PubMed
Trends Microbiol. 1997 Jul;5(7):282-8 PubMed
Microbiol Immunol. 1995;39(6):401-4 PubMed
Eur J Clin Microbiol Infect Dis. 1990 Oct;9(10):762-7 PubMed
Microbiol Immunol. 1996;40(9):607-10 PubMed
Infect Immun. 1983 Mar;39(3):1300-6 PubMed
FEMS Microbiol Lett. 1995 Feb 15;126(2):189-95 PubMed
Biochem Biophys Res Commun. 1997 Dec 18;241(2):341-6 PubMed
J Immunol. 1998 Oct 15;161(8):4301-8 PubMed
Exp Cell Res. 1998 Jul 10;242(1):341-50 PubMed
FEMS Immunol Med Microbiol. 2000 May;28(1):37-41 PubMed
J Clin Microbiol. 1987 Jan;25(1):146-9 PubMed
Can J Microbiol. 1994 Apr;40(4):286-91 PubMed
Eur J Epidemiol. 1996 Apr;12(2):191-8 PubMed
Aggregation of Lactobacilli and Bifidobacteria with Escherichia coli O157
Proteolytic activity in Serratia marcescens clinical isolates
